Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap ($49.01 Million)
Market Cap & Net Worth: Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. market cap. Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (IS:ONCSM) has a market capitalization of $49.01 Million (TL2.19 Billion) as of November 8, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #21732 globally and #295 in its home market, demonstrating a 2.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s stock price TL91.75 by its total outstanding shares 23850000 (23.85 Million). Also see ONCSM cash generation efficiency for how efficiently the company converts equity into cash flow.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap History (2023–2026)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. market cap history from 2023 to 2026. Data shows growth from $79.91 Million to $49.01 Million (50.35% CAGR). Check Oncosem Onkolojik Sistemler Sanayi ve Ti stock quote for real-time trading data and today's change.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.33x
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market cap is 0.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $79.91 Million | $240.51 Million | -$79.81 Million | 0.33x | N/A |
Competitor Companies of ONCSM by Market Capitalization
Companies near Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. in the global market cap rankings as of November 8, 2026. Also see Oncosem Onkolojik Sistemler Sanayi ve Ti assets under control for a full breakdown of the balance sheet.
Key companies related to Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2023–2026)
Market capitalization of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2023 to today. Between 2023 and today, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market cap moved from $79.91 Million to $ 49.01 Million, with a yearly change of 50.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL49.01 Million | -65.11% |
| 2025 | TL140.49 Million | +147.88% |
| 2024 | TL56.68 Million | -29.08% |
| 2023 | TL79.91 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $49.01 Million USD |
| MoneyControl | $49.01 Million USD |
| MarketWatch | $49.01 Million USD |
| marketcap.company | $49.01 Million USD |
| Reuters | $49.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins,… Read more